News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Tokai Pharmaceuticals Reports $10M Round, Developing Drug for Prostate Cancer



5/8/2009 9:16:48 AM

Xconomy --Tokai Pharmaceuticals, a Cambridge, MA-based drug developer, has landed $10 million of a proposed $22 million round of private equity financing, according to an SEC filing. The startup says that its main focus is advancing a new drug for prostate cancer that is unable to be treated with standard testosterone-blocking therapies, according to its website.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES